Factors that influence a patient's decision to engage in genetic research.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 30 01 2022
accepted: 11 04 2023
medline: 9 6 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: epublish

Résumé

The most challenging step in clinical research studies is patient recruitment. Many research studies do not reach their targets because of participant rejection. The purpose of this study was to assess patient as well as the community knowledge, motivation, and barriers to participate in genetic research. A cross-section study was conducted between September 2018 and February 2020 using face-to-face interviews with candidate patients from outpatient clinics at King Fahad Medical City (KFMC), Riyadh, Saudi Arabia. Additionally, an online survey was conducted to assess the community's knowledge, motivation and barriers to participate in genetic research studies. In total, 470 patients were interviewed for this study, with 341 being successfully recruited for the face to face interview, and the other patients being refused owing to time constraints. The majority percentage of the respondents were females. The respondents' mean age was 30, and 52.6% reported having a college degree. The survey results from 388 participants illustrated that around 90% of the participants, participated voluntarily due to a good understanding of genetics studies. The majority held positive attitudes toward being part of genetic research, which exceeded the reported motivation score of >75%. The survey indicated that >90% of individuals were willing to participate to acquire therapeutic benefits or to receive continued aftercare. However, 54.6% of survey participants were worried about the side effects and the risks involved in genetic testing. A higher proportion (71.4%) of respondents reported that lack of knowledge about genetic research was one of the barriers to rejecting participation. Respondents reported relatively high motivation and knowledge for participation in genetic research. However, study participants reported "do not know enough about genetic research" and "lack of time during clinic visit" as a barrier for participation in genetic research.

Identifiants

pubmed: 37283985
doi: 10.3389/fpubh.2023.865786
pmc: PMC10239877
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

865786

Informations de copyright

Copyright © 2023 Almutairi, Alqubaishi, Alsolm, Binowayn, Almohammad, Wani, Ababtain, Alkadi, Alrashed, Althagafi and Abu-Safieh.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer HL declared a shared affiliation with the authors MA, AB, UA, RA, TW, EA to the handling editor at the time of review.

Références

BMJ Open. 2019 Oct 22;9(10):e031305
pubmed: 31641002
Br J Cancer. 2000 Jun;82(11):1783-8
pubmed: 10839291
J Empir Res Hum Res Ethics. 2016 Feb;11(1):21-30
pubmed: 26928896
Genet Test Mol Biomarkers. 2013 Apr;17(4):327-35
pubmed: 23406207
Stat Med. 1998 Apr 30;17(8):857-72
pubmed: 9595616
Clin Trials. 2015 Feb;12(1):77-83
pubmed: 25475878
PLoS One. 2016 Feb 05;11(2):e0143893
pubmed: 26848750
Malawi Med J. 2008 Jun;20(2):57-63
pubmed: 19537434
Bioethics. 2004 Sep;18(5):448-70
pubmed: 15462026
BMJ Open. 2013 Feb 07;3(2):
pubmed: 23396504
Public Health Genomics. 2016;19(5):260-8
pubmed: 27544410
BMC Med Res Methodol. 2014 Jan 23;14:10
pubmed: 24456229
Front Genet. 2019 Jun 14;10:548
pubmed: 31258547
J Clin Med Res. 2014 Jun;6(3):162-72
pubmed: 24734142
BMJ Open. 2012 Jan 06;2(1):e000496
pubmed: 22228729
Eur J Hum Genet. 2011 Dec;19(12):1213-7
pubmed: 21731059
Clin Trials. 2011 Oct;8(5):616-23
pubmed: 21813584
Perspect Clin Res. 2016 Jul-Sep;7(3):137-43
pubmed: 27453831
J Med Ethics. 2005 Jul;31(7):385-92
pubmed: 15994356
Genome Med. 2011 Jun 15;3(6):39
pubmed: 21676259
Trials. 2006 Apr 07;7:9
pubmed: 16603070
Health Expect. 2015 Oct;18(5):1413-25
pubmed: 23968492
Patient Educ Couns. 2008 Nov;73(2):280-5
pubmed: 18715740

Auteurs

Amal Almutairi (A)

King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.

Fatimah Abdulrahman Alqubaishi (FA)

King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.

Ebtehal A Alsolm (EA)

Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.

Albandari Binowayn (A)

King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.

Rania Almohammad (R)

Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.

Tariq Wani (T)

Research Services, Department of Biostatistics, Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.

Aljohara Ababtain (A)

Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.

Udai Alkadi (U)

Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.

May M Alrashed (MM)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

Malak Althagafi (M)

Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.

Leen Abu-Safieh (L)

Bioinformatics and Computational Biology Department, Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH